123
Views
0
CrossRef citations to date
0
Altmetric
CASE REPORT

Blastic Plasmacytoid Dendritic Cell Neoplasm with Lung Involvement and Cytopenia: A Case Report and a Literature Review

ORCID Icon, ORCID Icon, , &
Pages 2211-2216 | Received 10 May 2023, Accepted 01 Aug 2023, Published online: 11 Aug 2023

References

  • Sweet K. Blastic plasmacytoid dendritic cell neoplasm: diagnosis, manifestations, and treatment. Curr Opin Hematol. 2020;27(2):103–107. doi:10.1097/MOH.0000000000000569
  • Garnache-Ottou F, Vidal C, Biichle S, et al. How should we diagnose and treat blastic plasmacytoid dendritic cell neoplasm patients? Blood Adv. 2019;3(24):4238–4251. doi:10.1182/bloodadvances.2019000647
  • Hirner JP, O’Malley JT, LeBoeuf NR. Blastic plasmacytoid dendritic cell neoplasm: the dermatologist’s perspective. Hematol Oncol Clin North Am. 2020;34(3):501–509. doi:10.1016/j.hoc.2020.01.001
  • Pagano L, Valentini CG, Grammatico S, Pulsoni A. Blastic plasmacytoid dendritic cell neoplasm: diagnostic criteria and therapeutical approaches. Br J Haematol. 2016;174(2):188–202. doi:10.1111/bjh.14146
  • Cheng W, Yu TT, Tang AP, He Young K, Yu L. Blastic plasmacytoid dendritic cell neoplasm: progress in cell origin, molecular biology, diagnostic criteria and therapeutic approaches. Curr Med Sci. 2021;41(3):405–419. doi:10.1007/s11596-021-2393-3
  • Sapienza MR, Pileri S. Molecular features of blastic plasmacytoid dendritic cell neoplasm: DNA mutations and epigenetics. Hematol Oncol Clin North Am. 2020;34(3):511–521. doi:10.1016/j.hoc.2020.01.002
  • Sakamoto K, Takeuchi K. Cytogenetics of blastic plasmacytoid dendritic cell neoplasm: chromosomal rearrangements and DNA copy-number alterations. Hematol Oncol Clin North Am. 2020;34(3):523–538. doi:10.1016/j.hoc.2020.01.003
  • Xue T, Budde LE. Immunotherapies targeting CD123 for blastic plasmacytoid dendritic cell neoplasm. Hematol Oncol Clin North Am. 2020;34(3):575–587. doi:10.1016/j.hoc.2020.01.006
  • Zhang Y, Sokol L. Clinical Insights into the management of blastic plasmacytoid dendritic cell neoplasm. Cancer Manag Res. 2022;14:2107–2117. doi:10.2147/CMAR.S330398
  • Pemmaraju N, Lane AA, Sweet KL, et al. Tagraxofusp in blastic plasmacytoid dendritic-cell neoplasm. N Engl J Med. 2019;380(17):1628–1637. doi:10.1056/NEJMoa1815105
  • Sapienza MR, Pileri A, Derenzini E, et al. Blastic plasmacytoid dendritic cell neoplasm: state of the art and prospects. Cancers. 2019;11(5):595. doi:10.3390/cancers11050595